Search

Your search keyword '"Imatinib mesylate -- Planning"' showing total 1 results
Start Over Descriptor "Imatinib mesylate -- Planning"

Refine your results

1 results on '"Imatinib mesylate -- Planning"'

1. Breckenridge Announces Final Approval of its ANDA for Imatinib Mesylate Tablets (RLD: Gleevec(r))

Subjects
Novartis AG -- Planning, Pharmaceutical industry -- Planning, Drug approval, Imatinib mesylate -- Planning, Antineoplastic agents, Generic drugs, Company business planning, General interest, News, opinion and commentary, Gleevec (Medication)
Abstract

BOCA RATON: Breckenridge Pharmaceutical, Inc. has issued the following press release: Breckenridge Pharmaceutical, Inc. announced that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results